Back
NewAmsterdam Pharma Co NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Sell
46
NAMS
NewAmsterdam Pharma Co NV
Last Price:
$25.90
Seasonality Move:
37.93%
Sell
12
PRQR
ProQR Therapeutics NV
Last Price:
$2.76
Seasonality Move:
-17.34%
Sell
46
NewAmsterdam Pharma Co NV (NAMS)
is a Sell
Is NewAmsterdam Pharma Co NV a Buy, Sell or Hold?
-
The current NewAmsterdam Pharma Co NV [NAMS] share price is $25.94. The Score for NAMS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NAMS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
12
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
-
The current ProQR Therapeutics NV [PRQR] share price is $2.76. The Score for PRQR is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
PRQR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NAMS Stock Price Chart
What is NewAmsterdam Pharma Co NV's stock price today?
-
The NewAmsterdam Pharma Co NV share price today is $25.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAMS is experiencing slight buying pressure.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $2.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing slight buying pressure.
NAMS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.2 | Buy |
Relative Strength Index (14 RSI): | 62.17 | Buy |
Chaikin Money Flow: | 112221 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.5 - 26.7) | Buy |
Bollinger Bands (100): | (15.98 - 23.22) | Buy |
PRQR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 42.77 | Sell |
Chaikin Money Flow: | 45157 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.62 - 3.5) | Sell |
Bollinger Bands (100): | (1.9 - 3.54) | Buy |
NAMS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.86 | Buy |
20-day SMA: | 24.58 | Buy |
50-day SMA: | 22.37 | Buy |
200-day SMA: | 19.72 | Buy |
8-day EMA: | 25.74 | Buy |
20-day EMA: | 24.72 | Buy |
50-day EMA: | 22.69 | Buy |
200-day EMA: | 19.45 | Buy |
PRQR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.7 | Buy |
20-day SMA: | 2.91 | Sell |
50-day SMA: | 3.35 | Sell |
200-day SMA: | 2.33 | Buy |
8-day EMA: | 2.73 | Buy |
20-day EMA: | 2.9 | Sell |
50-day EMA: | 3.02 | Sell |
200-day EMA: | 2.5 | Buy |
NewAmsterdam Pharma Co NV Earnings Growth & NAMS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.08 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.03 per share.
NewAmsterdam Pharma Co NV Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProQR Therapeutics NV Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |